X
LLY icon

Xponance’s Eli Lilly LLY Stock Holding History

Xponance’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$209M Buy
226,843
+18,521
+9% +$18.8M 1.48% 10
2025
Q4 		$224M Buy
208,322
+11,263
+6% +$10.8M 1.68% 10
2025
Q3 		$150M Sell
197,059
-871
-0.4% -$648K 1.19% 10
2025
Q2 		$154M Buy
197,930
+6,727
+4% +$5.23M 1.29% 10
2025
Q1 		$158M Buy
191,203
+4,673
+3% +$3.89M 1.53% 10
2024
Q4 		$144M Sell
186,530
-159
-0.1% -$132K 1.31% 10
2024
Q3 		$165M Sell
186,689
-8,135
-4% -$7.31M 1.6% 10
2024
Q2 		$176M Sell
194,824
-262
-0.1% -$210K 1.8% 8
2024
Q1 		$152M Buy
195,086
+4,077
+2% +$2.9M 1.59% 8
2023
Q4 		$111M Buy
191,009
+1,718
+0.9% +$1M 1.33% 10
2023
Q3 		$102M Buy
189,291
+590
+0.3% +$304K 1.38% 9
2023
Q2 		$88.5M Buy
188,701
+21,738
+13% +$9.12M 1.18% 11
2023
Q1 		$57.3M Buy
166,963
+4,192
+3% +$1.41M 0.84% 16
2022
Q4 		$59.5M Buy
162,771
+16,459
+11% +$5.84M 0.96% 14
2022
Q3 		$47.3M Buy
146,312
+10,436
+8% +$3.31M 0.91% 13
2022
Q2 		$44.1M Buy
135,876
+748
+0.6% +$225K 0.89% 13
2022
Q1 		$38.7M Buy
135,128
+15,489
+13% +$3.99M 0.64% 21
2021
Q4 		$33M Sell
119,639
-3,063
-2% -$776K 0.52% 31
2021
Q3 		$28.4M Sell
122,702
-11,206
-8% -$2.77M 0.54% 28
2021
Q2 		$30.7M Sell
133,908
-15,512
-10% -$3.12M 0.56% 25
2021
Q1 		$27.9M Sell
149,420
-455
-0.3% -$89K 0.59% 30
2020
Q4 		$25.3M Buy
149,875
+851
+0.6% +$127K 0.55% 31
2020
Q3 		$22.1M Sell
149,024
-7,957
-5% -$1.23M 0.54% 33
2020
Q2 		$25.8M Buy
+156,981
New +$24.1M 0.67% 25

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Xponance's LLY Position: Q1 2026 in Review

Xponance increased its Eli Lilly (LLY) stake by 8.9% in Q1 2026, buying an estimated $18.8M and bringing the position to 226,843 shares worth $209M. The position accounts for 1.48% of the portfolio, ranked #10.

Xponance first reported a position in LLY in Q2 2020 and has held it in 24 quarters since. The position peaked at $224M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Xponance held 226,843 shares of Eli Lilly worth $209M as of Q1 2026.
  • Xponance bought 18,521 Eli Lilly shares in Q1 2026, an estimated $18.8M.
  • Eli Lilly made up 1.48% of Xponance's portfolio in Q1 2026, its #10 holding.
  • Xponance first reported a position in Eli Lilly in Q2 2020 and has held it in 24 quarters since.
  • Xponance's Eli Lilly position peaked at $224M in Q4 2025.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Xponance's 13F filing for Q1 2026, filed 13 May 2026.